EUVIMEDEUVIMED entdecken
Crossref

The Contradictory Effects of SPTLC1 on Clear Cell Renal Carcinoma Sensitivity to Sunitinib Mediated by Androgen Receptor

Liqiong Liao iD, Zhixiong Zhang, Zhenhua Li, Daqiang Wei, Yanni Xie, Haodong Zeng, Hongyang Zhao, Yuhao Zhou, Di Gu, Xiaolu Duan iD

Molecular Carcinogenesis · 2025

DOI: 10.1002/mc.70023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2025. Verfasst von Liqiong Liao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Urological Diseases, Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital o…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Sunitinib, Kidney Neoplasms, Receptors, Androgen. Die Arbeit nennt 40 Literaturangaben. Gefördert von: This study was financed by grants from the Characteristic Innovation project of Guangdong Province Education Department (2019KTSCX140), the Scientific research….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Serine palmitoyltransferase long chain‐1 (SPTLC1) is a key enzyme in ceramide synthesis, previously identified as a suppressor of tumorigenesis in clear cell renal carcinoma (ccRCC). Although elevated levels of very long‐chain ceramides are associated with the canonical multidrug resistance in ccRCC, the specific role of SPTLC1 in modulating the sensitivity of ccRCC to sunitinib remains unclear. In this study, we found that SPTLC1 overexpression could enhance the sensitivities of 786‐O and OSRC‐2 cells to sunitinib via downregulating CerS2 expression and long‐chain ceramide levels. In contrast, SPTLC1 upregulated CerS2 expression and long‐chain ceramide levels in A498 cells, yet without a significant impact on its sensitivity to sunitinib. In addition, overexpression of CerS2 significantly attenuated SPTLC1‐enhanced sensitivities of 786‐O and OSRC‐2 cells to sunitinib, whereas CerS2 knockdown obviously enhanced the sensitivity of A498 cells to sunitinib. Moreover, androgen receptor (AR) expression was significantly decreased in SPTLC1‐overexpressed 786‐O cells and forced AR expression could obviously attenuate the downregulation of CerS2 expression induced by SPTLC1 in 786‐O cells, whereas opposite results were observed in A498 cells, suggesting that the contradictory effects of SPTLC1 on CerS2 expression were modulated by AR. Taken together, our results demonstrated that the contradictory effects of SPTLC1 on clear cell renal carcinoma sensitivity to sunitinib were caused by AR‐mediated CerS2 expression, thus revealing a novel role and mechanism of SPTLC1 in the regulation of ccRCC sensitivity to sunitinib.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellSunitinibKidney NeoplasmsReceptors, AndrogenDrug Resistance, NeoplasmSerine C-PalmitoyltransferaseTumor Suppressor ProteinsSphingosine N-AcyltransferaseHumansCell Line, TumorGene Expression Regulation, NeoplasticMembrane ProteinsAntineoplastic AgentsCeramidesCell Proliferation

Stichwörter der Autor:innen

CerS2SPTLC1androgen receptorclear cell renal carcinomasunitinib

Substanzen

SunitinibReceptors, AndrogenAR protein, humanSerine C-PalmitoyltransferaseCERS2 protein, humanTumor Suppressor ProteinsSphingosine N-AcyltransferaseMembrane ProteinsAntineoplastic AgentsCeramides

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Urological Diseases, Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Urology, Guangz…
  • Department of Pharmacy, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Department of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

ORCID-Profile: Liqiong Liao, Xiaolu Duan

Förderung

  • This study was financed by grants from the Characteristic Innovation project of Guangdong Province Education Department (2019KTSCX140), the Scientific research…

Zitieren

APA

Liao, L., Zhang, Z., Li, Z., Wei, D., Xie, Y., Zeng, H., Zhao, H., Zhou, Y., Gu, D., & Duan, X. (2025). The Contradictory Effects of SPTLC1 on Clear Cell Renal Carcinoma Sensitivity to Sunitinib Mediated by Androgen Receptor. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70023

Vancouver

Liao L, Zhang Z, Li Z, Wei D, Xie Y, Zeng H, et al. The Contradictory Effects of SPTLC1 on Clear Cell Renal Carcinoma Sensitivity to Sunitinib Mediated by Androgen Receptor. Molecular Carcinogenesis. 2025. doi:10.1002/mc.70023

BibTeX
@article{Liao2025,
  author = {Liao, Liqiong and Zhang, Zhixiong and Li, Zhenhua and Wei, Daqiang and Xie, Yanni and Zeng, Haodong and Zhao, Hongyang and Zhou, Yuhao and Gu, Di and Duan, Xiaolu},
  title = {The Contradictory Effects of SPTLC1 on Clear Cell Renal Carcinoma Sensitivity to Sunitinib Mediated by Androgen Receptor},
  journal = {Molecular Carcinogenesis},
  year = {2025},
  doi = {10.1002/mc.70023}
}
Kostenlos starten →